Erica Wee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Erica Wee has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Emily DeWit
Division of Endocrinology, Children’s Mercy Kansas City, Kansas City, MO
1 shared publication- Emily Paprocki
Division of Pediatric Endocrinology and Diabetes, Children's Mercy Kansas City University of Missouri‐Kansas City Kansas City Missouri USA
1 shared publication Erica Zarse
Division of Endocrinology, Children’s Mercy Kansas City, Kansas City, MO
1 shared publicationHeather Feingold
Division of Endocrinology, Children’s Mercy Kansas City, Kansas City, MO
1 shared publicationJaimie Contreras
Division of Endocrinology, Children’s Mercy Kansas City, Kansas City, MO
1 shared publication- John Herriges
University of Missouri Kansas City—School of Medicine
1 shared publication
Latest Publications
- 18 August 2023
- Published by American Diabetes Association in Clinical Diabetes
- Vol. 42 (1) , 156-160
Improving Planning for Transition to Adult Care in a Pediatric Diabetes Clinic
Quality Improvement Success Stories are published by the American Diabetes Association in collaboration with the American College of Physicians and the National Diabetes Education Program. This series is intended to highlight best practices and strategies from programs and clinics that have successfully improved the quality of care for people with diabetes or related conditions. Each article in the series is reviewed and follows a standard format developed by the editors of Clinical Diabetes. The following article describes efforts at a large midwestern pediatric health system to improve planning for patients’ transition from pediatric to adult diabetes care settings.
- 18 August 2023
- Published by American Diabetes Association in Clinical Diabetes
- Vol. 42 (1) , 156-160
Improving Planning for Transition to Adult Care in a Pediatric Diabetes Clinic
Quality Improvement Success Stories are published by the American Diabetes Association in collaboration with the American College of Physicians and the National Diabetes Education Program. This series is intended to highlight best practices and strategies from programs and clinics that have successfully improved the quality of care for people with diabetes or related conditions. Each article in the series is reviewed and follows a standard format developed by the editors of Clinical Diabetes. The following article describes efforts at a large midwestern pediatric health system to improve planning for patients’ transition from pediatric to adult diabetes care settings.
- Open Access
- 26 June 2023
- Published by Hindawi Limited in Case Reports in Endocrinology
- Vol. 2023, 1-5
Hyperinsulinemic Hypoglycemia and Growth Hormone Deficiency Secondary to 20p11 Deletion
Hypoglycemia is concerning for neurological complications in infants and children. Determining the cause of hypoglycemia is essential in providing appropriate treatment. Hyperinsulinism and growth hormone deficiency are known causes of hypoglycemia but are not commonly found together. We report a 4-month-old boy who presented with severe hypoglycemia and was found to have both hyperinsulinism and growth hormone deficiency. Treatment with both recombinant human growth hormone and diazoxide led to blood glucose normalization. Subsequently, he was found to have a genetic diagnosis of 20p11.22p11.21 deletion. 20p11 deletions have been associated with hypopituitarism, most commonly seen in growth hormone deficiency causing hypoglycemia. This case is one of a few to report hyperinsulinism as a manifestation of this deletion.
- 26 June 2023
- Published by Hindawi Limited in Case Reports in Endocrinology
- Vol. 2023, 1-5
Open AccessHyperinsulinemic Hypoglycemia and Growth Hormone Deficiency Secondary to 20p11 Deletion
Hypoglycemia is concerning for neurological complications in infants and children. Determining the cause of hypoglycemia is essential in providing appropriate treatment. Hyperinsulinism and growth hormone deficiency are known causes of hypoglycemia but are not commonly found together. We report a 4-month-old boy who presented with severe hypoglycemia and was found to have both hyperinsulinism and growth hormone deficiency. Treatment with both recombinant human growth hormone and diazoxide led to blood glucose normalization. Subsequently, he was found to have a genetic diagnosis of 20p11.22p11.21 deletion. 20p11 deletions have been associated with hypopituitarism, most commonly seen in growth hormone deficiency causing hypoglycemia. This case is one of a few to report hyperinsulinism as a manifestation of this deletion.